Drug Testing in Clinical and Pain Management Settings

Confirm Biosciences is pleased to provide popular drug testing products used by clinical laboratories and pain management facilities. Any facility that is involved in prescribing potentially addictive drugs has to be cautious and drug testing kits can help these facilities take the necessary precautions to prevent drug abuse and ensure that patients are using the prescribed drugs properly.

With our CLIA Waived and FDA Approved urine drug screening products, you can:

  • Reduce the risk of a patient’s misuse or abuse of a prescribed medication
  • Gain insight into the likelihood that a patient is taking his or her medication as prescribed
  • Learn about controlled substances a patient is taking
  • Find out if the patient is taking not enough medication or too much medication

Confirm Biosciences is committed to helping your pain management program achieve a higher level of performance with our CLIA Waived drug testing panels. 

CLIA Waived Drug Testing Levels and Detection Periods

Drug Name: Abbr: Detection Period Cutoff:
Amphetamine AMP 2-4 Days 1000ng/mL
Barbiturates BAR 4-7 Days 300ng/mL
Benzodiazepines BZO 3-7 Days 300ng/mL
Buprenorphine  BUP 1-3 Days 10 ng/mL
Cocaine COC 2-4 Days 300ng/mL
Ecstasy MDMA 1-3 Days 500ng/mL
Marijuana THC 15-30 Days 50ng/mL
Methadone MTD 1-3 Days 300 ng/mL
Methamphetamine mAMP 3-5 Days 1000ng/mL
Morphine MOR 2-4 Days 300ng/mL
Opiates OPI 2-4 Days 2000ng/mL
Oxycodone OXY 2-4 Days 100ng/mL
Phencyclidine PCP 7-14 days 25 ng/mL
Propoxyphene PPX  1-2 Days 300ng/mL
Tricyclic antidepressants TCA 2-10 Days 1000ng/mL

Our products are a staple in the clinical testing industry and can be used to gain precise and exact results. Some of our top-sellers include:

Related Links